Quantcast

Latest Parkinson's disease Stories

2014-10-31 08:27:10

MIAMI, Oct. 31, 2014 /PRNewswire-USNewswire/ -- The Jean and Paul Amos Parkinson's Disease and Movement Disorders Program at Emory University has been designated a Center of Excellence by the National Parkinson Foundation (NPF). This competitive designation is the highest recognition offered by NPF to a Parkinson's specialty clinic and represents the consensus of peers and leaders in the field that the Emory Center is among the world's leading centers for Parkinson's research,...

2014-10-30 12:29:23

Collaboration to Expand Pioneering Education Program NEW YORK, Oct. 30, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Disease Foundation® (PDF®) and the Edmond J. Safra Foundation announced today their collaboration on expanding and enhancing The Edmond J. Safra Visiting Nurse Faculty Program to improve care for the nearly one million people in the United States living with Parkinson's disease. http://photos.prnewswire.com/prnvar/20141030/155543LOGO It is estimated that the...

2014-10-29 16:28:45

REHOVOT, Israel, October 29, 2014 /PRNewswire/ -- Company also reports encouraging partial results from Phase IIa study of continuous, subcutaneously delivered high-dose liquid levodopa/carbidopa (ND0612H) therapy for advanced patients Data presented at the Michael J. Fox Foundation 2014 Parkinson's Disease Therapeutics Conference NeuroDerm Ltd., a clinical-stage pharmaceutical...

2014-10-26 23:01:58

Online course will boast global access to this highly in-demand training. Tucson, AZ (PRWEB) October 26, 2014 LSVT Global, Inc. is pleased to announce that its Online LSVT BIG Training and Certification Workshop went “live” on October 23, 2014. This new online course was developed in response to the overwhelming demand for the Live LSVT BIG Training and Certification Workshops that have been consistently sold out within the United States and internationally. The LSVT protocols...

2014-10-24 08:26:10

BOSTON, Oct. 24, 2014 /PRNewswire/ -- Rhythm announced today the presentation of results from a Phase 2a clinical trial assessing the safety and efficacy of relamorelin (RM-131) in 48 patients with chronic constipation. Analysis of the data indicates that relamorelin administered once daily for two weeks in patients with chronic constipation significantly improves constipation symptoms, along with accelerating colonic transit. The study results were presented in a late-breaker session at the...

2014-10-23 23:03:53

Alice Lazzarini, PhD, and internationally recognized researcher in neurogenetic disorders, announces the donation of a portion of proceeds from Both Sides Now: A Journey From Researcher to Patient to the American Parkinson Disease Association(APDA) New York, NY (PRWEB) October 23, 2014 Dr. Lazzarini's support through the sales of her book will raise funds to help Ease the Burden – Find the Cure for the 1 million individuals in the United States living with Parkinson disease. Both...

2014-10-23 08:34:33

REHOVOT, Israel, October 23, 2014 /PRNewswire/ -- NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that top-line results for ND0612L from a phase II study in patients with moderate Parkinson's patients, and preliminary interim results from a phase IIA study of ND0612H and ND0612L in advanced Parkinson's patients, will be presented at The Michael J. Fox Foundation's 2014 Parkinson's Disease...

2014-10-21 16:26:03

ATLANTA, Oct. 21, 2014 /PRNewswire-USNewswire/ -- In honor of Lewy Body Dementia (LBD) Awareness Month, the Lewy Body Dementia Association proudly unveils, "The Profiles of LBD," a portrait series of families living with the disease. Taken by world-renowned professional photographer, Robert Whitman, the series encapsulates the love between those afflicted with LBD and their caregivers, despite the struggles they face together every day managing a relatively unknown, yet very common,...

2014-10-20 12:29:44

The Parkinson Alliance Reports Findings Pertaining to Autonomic Dysfunction in Parkinson's KINGSTON, N.J., Oct. 20, 2014 /PRNewswire-USNewswire/ -- New findings from The Parkinson Alliance (PA) survey entitled "Autonomic Dysfunction in Parkinson's Disease With and Without Deep Brain Stimulation" show that autonomic dysfunction was highly prevalent in Parkinson's disease (PD), regardless of age and disease duration. The autonomic nervous system controls a number of functions in the...

2014-10-15 16:29:22

COLUMBUS, Ohio, Oct. 15, 2014 /PRNewswire/ -- OhioHealth "Delay the Disease", an evidenced-based fitness program designed for people with Parkinson's Disease, is one of the newest members of the OhioHealth family of neuroscience programs. The community-based wellness program is designed to empower those living with Parkinson's Disease by optimizing their physical function and helping to delay the progression of symptoms associated with Parkinson's Disease. To view the multimedia...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.